Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2020 Volume 19 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function

  • Authors:
    • Xin Li
    • Yun‑Xiao Wang
    • Ping Shi
    • Yan‑Ping Liu
    • Ting Li
    • Shu‑Qin Liu
    • Chen‑Jing Wang
    • Le‑Xin Wang
    • Yu Cao
  • View Affiliations / Copyright

    Affiliations: Office of Drug Clinical Trial Management, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China, Department of Cardiology, Liaocheng People's Hospital, Liaocheng, Shandong 252000, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2690-2696
    |
    Published online on: February 4, 2020
       https://doi.org/10.3892/etm.2020.8490
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Icariin, a flavonoid isolated from traditional oriental herbal medicines, has been demonstrated to exhibit several health benefits in animal models and in humans. The aim of the present study was to investigate the effect of Icariin on hyperglycemia in type 2 diabetes mellitus (T2DM) in rats. A model of diabetes was established in 50 Sprague Dawley rats using a high‑sugar and high‑fat diet and peritoneal injection of streptozotocin. Diabetic rats were divided into five groups: Diabetic control; metformin; and rats treated with three different doses of Icariin, 5, 10 and 20 mg/kg. Body weight and blood glucose levels were measured, and serum adiponectin levels, expression of phospho‑AMP mediated protein kinase (p‑AMPK) and glucose transporter isoform 4 (GLUT‑4) were measured using ELISA, Realtime PCR and western blotting, respectively. Diabetic rats without drug treatment exhibited reduced body weight, increased blood glucose levels and decreased the number of islets. In T2DM rats treated with 10 or 20 mg/kg Icariin, the blood glucose levels were reduced, whereas serum adiponectin levels were not affected. Additionally, the mRNA and protein expression levels of p‑AMPK and GLUT‑4 protein were increased in the T2DM rats treated with Icariin. In conclusion, in the diabetes rat model, Icariin alleviated the severity of diabetes, and the effects may be associated with reduction of hyperglycemia by activating an AMPK/GLUT‑4 pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE and Makaroff LE: IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 128:40–50. 2017.PubMed/NCBI View Article : Google Scholar

2 

Constantin RP, Constantin RP, Bracht A, Yamamoto NS, Ishii-Iwamoto EL and Constantin J: Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis. Fitoterapia. 92:148–162. 2014.PubMed/NCBI View Article : Google Scholar

3 

Li WL, Zheng HC, Bukuru J and De Kimpe N: Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 92:1–21. 2004.PubMed/NCBI View Article : Google Scholar

4 

Hajiaghaalipour F, Khalilpourfarshbafi M and Arya A: Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. Int J Biol Sci. 11:508–524. 2015.PubMed/NCBI View Article : Google Scholar

5 

Xiong W, Ma X, Wu Y, Chen Y, Zeng L, Liu J, Sun W, Wang D and Hu Y: Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A. BMC Vet Res. 11(205)2015.PubMed/NCBI View Article : Google Scholar

6 

He W, Sun H, Yang B, Zhang D and Kabelitz D: Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung. 45:910–913. 1995.PubMed/NCBI

7 

Makarova MN, Pozharitskaya ON, Shikov AN, Tesakova SV, Makarov VG and Tikhonov VP: Effect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in rats. J Ethnopharmacol. 114:412–416. 2007.PubMed/NCBI View Article : Google Scholar

8 

Xu HB and Huang ZQ: Vasorelaxant effects of icariin on isolated canine coronary artery. J Cardiovasc Pharmacol. 49:207–213. 2007.PubMed/NCBI View Article : Google Scholar

9 

Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY and Wei S: Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol. 11:890–898. 2011.PubMed/NCBI View Article : Google Scholar

10 

Chen YJ, Zheng HY, Huang XX, Han SX, Zhang DS, Ni JZ and He XY: Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple-transgenic alzheimer's disease mice. CNS Neurosci Ther. 22:63–73. 2016.PubMed/NCBI View Article : Google Scholar

11 

Qi MY, Kai-Chen Liu HR, Su YH and Yu SQ: Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor beta1 and type IV collagen expression in rats. J Ethnopharmacol. 138:731–736. 2011.PubMed/NCBI View Article : Google Scholar

12 

Xin H, Zhou F, Liu T, Li GY, Liu J, Gao ZZ, Bai GY, Lu H and Xin ZC: Icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo. Int J Mol Sci. 13:866–878. 2012.PubMed/NCBI View Article : Google Scholar

13 

Zhang ZB and Yang QT: The testosterone mimetic properties of icariin. Asian J Androl. 8:601–605. 2006.PubMed/NCBI View Article : Google Scholar

14 

Lu YF, Xu YY, Jin F, Wu Q, Shi JS and Liu J: Icariin is a PPARα activator inducing lipid metabolic gene expression in mice. Molecules. 19:18179–18191. 2014.PubMed/NCBI View Article : Google Scholar

15 

Hossain MM, Mukheem A and Kamarul T: The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. Life Sci. 135:55–67. 2015.PubMed/NCBI View Article : Google Scholar

16 

El Husseny MW, Mamdouh M, Shaban S, Ibrahim Abushouk A, Zaki MM, Ahmed OM and Abdel-Daim MM: Adipokines: Potential therapeutic targets for vascular dysfunction in type ii diabetes mellitus and obesity. J Diabetes Res. 2017(8095926)2017.PubMed/NCBI View Article : Google Scholar

17 

Gao Q, Yao X and Zheng J: MiR-323 inhibits prostate cancer vascularization through adiponectin receptor. Cell Physiol Biochem. 36:1491–1498. 2015.PubMed/NCBI View Article : Google Scholar

18 

Ye JM, Dzamko N, Hoy AJ, Iglesias MA, Kemp B and Kraegen E: Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats. Diabetes. 55:2797–2804. 2006.PubMed/NCBI View Article : Google Scholar

19 

Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, Summers SA, Hirshman MF and Goodyear LJ: Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes. 57:2958–2966. 2008.PubMed/NCBI View Article : Google Scholar

20 

Richter EA and Ruderman NB: AMPK and the biochemistry of exercise: Implications for human health and disease. Biochem J. 418:261–275. 2009.PubMed/NCBI View Article : Google Scholar

21 

Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A and Alessi DR: Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24:1810–1820. 2005.PubMed/NCBI View Article : Google Scholar

22 

Sharma AX, Quittner-Strom EB, Lee Y, Johnson JA, Martin SA, Yu X, Li J, Lu J, Cai Z, Chen S, et al: Glucagon receptor antagonism improves glucose metabolism and cardiac function by promoting AMP-mediated protein kinase in diabetic mice. Cell Rep. 22:1760–1773. 2018.PubMed/NCBI View Article : Google Scholar

23 

Na RS, Ma C, Liu QR, Wu LM, Zheng XL and Liu ZW: Itraconazole attenuates hepatic gluconeogenesis and promotes glucose uptake by regulating AMPK pathway. Exp Ther Med. 15:2165–2171. 2018.PubMed/NCBI View Article : Google Scholar

24 

Lowell BB and Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science. 307:384–387. 2005.PubMed/NCBI View Article : Google Scholar

25 

James DE, Strube M and Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature. 338:83–87. 1989.PubMed/NCBI View Article : Google Scholar

26 

Goodyear LJ and Kahn BB: Exercise, glucose transport, and insulin sensitivity. Annu Rev Med. 49:235–261. 1998.PubMed/NCBI View Article : Google Scholar

27 

Kraniou Y, Cameron-Smith D, Misso M, Collier G and Hargreaves M: Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol (1985). 88:794–796. 2000.PubMed/NCBI View Article : Google Scholar

28 

Cao S, Li B, Yi X, Chang B, Zhu B, Lian Z, Zhang Z, Zhao G, Liu H and Zhang H: Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes. PLoS One. 7(e51709)2012.PubMed/NCBI View Article : Google Scholar

29 

Leturque A, Loizeau M, Vaulont S, Salminen M and Girard J: Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes. 45:23–27. 1996.PubMed/NCBI View Article : Google Scholar

30 

Zhang Q, Xiao X, Zheng J, Li M, Yu M, Ping F, Wang T and Wang X: Liraglutide protects cardiac function in diabetic rats through the PPAα pathway. Biosci Rep, 2018 (Epub ahead of print).

31 

Ismail TA, Soliman MM and Nassan MA: Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus. Exp Ther Med. 9:1921–1930. 2015.PubMed/NCBI View Article : Google Scholar

32 

Wang X, Liu C, Xu Y, Chen P, Shen Y, Xu Y, Zhao Y, Chen W, Zhang X, Ouyang Y, et al: Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction. PLoS One. 12(e0174145)2017.PubMed/NCBI View Article : Google Scholar

33 

Du XX, Tao X, Liang S, Che JY, Yang S, Li H, Chen JG and Wang CM: Hypoglycemic effect of acidic polysaccharide from schisandra chinensis on T2D rats induced by high-fat diet combined with STZ. Biol Pharm Bull. 42:1275–1281. 2019.PubMed/NCBI View Article : Google Scholar

34 

Bahadoran Z, Mirmiran P and Azizi F: Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J Diabetes Metab Disord. 12(43)2013.PubMed/NCBI View Article : Google Scholar

35 

Zhang Y, Zhen W, Maechler P and Liu D: Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic β-cell survival and function via CREB. J Nutr Biochem. 24:638–646. 2013.PubMed/NCBI View Article : Google Scholar

36 

Kim DH, Jung HA, Sohn HS, Kim JW and Choi JS: Potential of Icariin metabolites from Epimedium koreanum Nakai as antidiabetic therapeutic agents. Molecules. 22:2017.PubMed/NCBI View Article : Google Scholar

37 

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7:941–946. 2001.PubMed/NCBI View Article : Google Scholar

38 

Nie JM and Li HF: Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus. Exp Ther Med. 14:2521–2526. 2017.PubMed/NCBI View Article : Google Scholar

39 

Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A and Hedayati M: The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother Res. 33:1374–1383. 2019.PubMed/NCBI View Article : Google Scholar

40 

Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, et al: Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis. Sci Rep. 9(3535)2019.PubMed/NCBI View Article : Google Scholar

41 

Tumminia A, Vinciguerra F, Parisi M, Graziano M, Sciacca L, Baratta R and Frittitta L: Adipose tissue, obesity and adiponect in: Role in endocrine cancer risk. Int J Mol Sci. 20(pii: E2863)2019.PubMed/NCBI View Article : Google Scholar

42 

Zeng F, Shi J, Long Y, Tian H, Li X, Zhao AZ, Li RF and Chen T: Adiponectin and endometrial cancer: A systematic review and meta-analysis. Cell Physiol Biochem. 36:1670–1678. 2015.PubMed/NCBI View Article : Google Scholar

43 

Duca FA, Côté CD, Rasmussen BA, Zadeh-Tahmasebi M, Rutter GA, Filippi BM and Lam TK: Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med. 21:506–511. 2015.PubMed/NCBI View Article : Google Scholar

44 

Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ and Winder WW: 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes. 48:1667–1671. 1999.PubMed/NCBI View Article : Google Scholar

45 

Farzaei MH, Singh AK, Kumar R, Croley CR, Pandey AK, Coy-Barrera E, Kumar Patra J, Das G, Kerry RG, Annunziata G, et al: Targeting inflammation by flavonoids: Novel therapeutic strategy for metabolic disorders. Int J Mol Sci. 20:2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li X, Wang YX, Shi P, Liu YP, Li T, Liu SQ, Wang CJ, Wang LX and Cao Y: Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function. Exp Ther Med 19: 2690-2696, 2020.
APA
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S. ... Cao, Y. (2020). Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function. Experimental and Therapeutic Medicine, 19, 2690-2696. https://doi.org/10.3892/etm.2020.8490
MLA
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S., Wang, C., Wang, L., Cao, Y."Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function". Experimental and Therapeutic Medicine 19.4 (2020): 2690-2696.
Chicago
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S., Wang, C., Wang, L., Cao, Y."Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2690-2696. https://doi.org/10.3892/etm.2020.8490
Copy and paste a formatted citation
x
Spandidos Publications style
Li X, Wang YX, Shi P, Liu YP, Li T, Liu SQ, Wang CJ, Wang LX and Cao Y: Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function. Exp Ther Med 19: 2690-2696, 2020.
APA
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S. ... Cao, Y. (2020). Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function. Experimental and Therapeutic Medicine, 19, 2690-2696. https://doi.org/10.3892/etm.2020.8490
MLA
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S., Wang, C., Wang, L., Cao, Y."Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function". Experimental and Therapeutic Medicine 19.4 (2020): 2690-2696.
Chicago
Li, X., Wang, Y., Shi, P., Liu, Y., Li, T., Liu, S., Wang, C., Wang, L., Cao, Y."Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function". Experimental and Therapeutic Medicine 19, no. 4 (2020): 2690-2696. https://doi.org/10.3892/etm.2020.8490
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team